Results 211 to 220 of about 3,871 (249)

8.CKD‒MBD

open access: yesNihon Toseki Igakkai Zasshi
openaire   +1 more source

The Impact of Common Medications on Male Fertility: An Updated Systematic Review

open access: yesAndrology, EarlyView.
ABSTRACT Background Compared with those of cytotoxic treatments, the potential effects of common medications on the fertility of men trying to conceive currently or planning to conceive in the future are less well described. The use of common medications may modify the gonadotropic axis, spermatogenesis, and epididymal maturation or alter male ...
Lina Jebli   +7 more
wiley   +1 more source

SURGELLA: A Scoping Review of Impella‐Assisted Hemodynamic Support in High‐Risk Non‐Cardiac Surgery

open access: yesArtificial Organs, EarlyView.
In selected patients with severe LV dysfunction, Impella‐supported non‐cardiac surgery may provide a temporary hemodynamic bridge to otherwise prohibitive procedures. Published evidence remains limited to a small number of highly selected cases, supporting technical feasibility rather than comparative benefit or generalizable safety.
Hussein Elghazaly   +6 more
wiley   +1 more source

5.CKD-MBD

open access: yesNihon Toseki Igakkai Zasshi
openaire   +1 more source

News on Biomarkers in CKD‐MBD

Seminars in Nephrology, 2014
The increased awareness of the potential role played by mineral and bone disorder in the appearance of cardiovascular disease in renal patients has produced research efforts aimed at discovering possible pathogenic links. Accordingly, the diagnostic significance of the classic bone markers of mineral disorders and of the new markers in the setting of ...
MAZZAFERRO, SANDRO   +5 more
openaire   +4 more sources

CKD-MBD: an endless story

Journal of Nephrology, 2011
Renal failure is a growing problem that involves a large part of the population and has a great social impact, with often incapacitating complications, mainly related to mineral bone disorders (MBD) and cardiovascular diseases. Analysis of the recent scientific literature confirms that a large number of chronic kidney disease (CKD) patients develop an ...
D. Brancaccio, M.G. Cozzolino
openaire   +2 more sources

CKD-MBD as a systemic disorder

Bone, 2009
The kidney is one of themost important organs in the regulation of mineral metabolism [1]. In patients with chronic kidney disease (CKD), abnormalities in mineral metabolism inevitably develop without appropriate management. The biochemical abnormalities result from disturbances in calcium, phosphate, PTH, FGF-23, and vitamin D metabolism [2].
Masafumi, Fukagawa, Tilman B, Drüeke
openaire   +2 more sources

Sclerostin and CKD-MBD

Current Osteoporosis Reports, 2015
Declining kidney function is associated with sequential systemic changes in mineral homeostasis leading to pathologic alterations in the cardiovascular system and the skeleton. One of the earliest changes in response to renal injury is the increased osteocyte production of secreted factors including the anti-anabolic protein, sclerostin.
openaire   +2 more sources

Sclerostin: a new biomarker of CKD–MBD

International Urology and Nephrology, 2019
The causes of the increased cardiovascular risk associated with kidney diseases partly reside in the chronic kidney disease-mineral bone disorder (CKD-MBD) syndrome. Three cardiovascular risk factors [hyperphosphatemia, vascular calcification, and elevated fibroblast growth factor 23 (FGF23)] levels have been discovered within the CKD-MBD over the last
Andreja Figurek   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy